Patterson Cos., Inc.

  • Market Cap: Small Cap
  • Industry: Medical Distributors
  • ISIN: US7033951036
USD
31.33
0.01 (0.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Patterson Cos., Inc. stock-summary
stock-summary
Patterson Cos., Inc.
Medical Distributors
Patterson Companies, Inc. is a value-added distributor focused on providing a customer experience to professionals in the dental and animal health markets. The Company operates through three segments: dental, animal health and corporate. Dental and Animal health are strategic business units that offer similar products and services to different customer bases. Dental provides a virtually complete range of consumable dental products, equipment and software and turnkey digital solutions. In addition it provides value-added services to dentists, dental laboratories, institutions and other healthcare professionals throughout North America. Animal health is a leading, full-line distributor of animal health products, services and technologies. Corporate segment is comprised of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources and facilities.
Company Coordinates stock-summary
Company Details
1031 Mendota Heights Rd , SAINT PAUL MN : 55120-1401
stock-summary
Tel: 1 651 68616001 686 6861600
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 91 Schemes (53.17%)

Foreign Institutions

Held by 144 Foreign Institutions (10.27%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. John Buck
Non-Executive Independent Chairman of the Board
Mr. Mark Walchirk
President, Chief Executive Officer, Director
Mr. Alex Blanco
Independent Director
Ms. Jody Feragen
Independent Director
Mr. Robert Frenzel
Independent Director
Mr. Francis Malecha
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,572 Million
(Quarterly Results - Jan 2025)
Net Profit:
31 Million
stock-summary
Industry

Medical Distributors

stock-summary
Market cap

USD 2,772 Million (Small Cap)

stock-summary
P/E

19.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

10,993.26%

stock-summary
Debt Equity

0.65

stock-summary
Return on Equity

14.45%

stock-summary
Price to Book

2.80